Profile

Epineuron accelerates nerve recovery with peripulse™, a Health Canada-approved, FDA Breakthrough Device. Its bioelectronic therapy supercharges nerve regeneration post-injury, significantly improving patient outcomes. At the MedTech Conference it aims to establish new investor relationships, secure its next investment, and forge strategic commercial partnerships to accelerate global market expansion and deliver its transformative nerve care solution to more patients.


Event details

Date: October 5 - 8, 2025

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

14 in total